Human immunodeficiency virus cascade–continuum of care stages and outcomes in a hospital in southern Brazil

Table 3 Comparison between patients who underwent follow-up at the Nossa Senhora da Conceição Hospital and external institutions using Pearson’s χ² test, n (%)

	HNSC	External	P value
Total	236	220
Gender			0.217
Female	127 (53.8)	131 (59.5)
Age (yr)			0.057
18-29	70 (29.7)	60 (27.3)
30-49	107 (45.3)	122 (55.5)
> 50	59 (25.0)	38 (17.3)
Race			0.945
White	167 (70.8)	155 (70.5)
Education			0.485
Illiterate	4 (1.7)	5 (2.3)
Elementary School	161 (68.2)	150 (68.5)
High School	61 (25.8)	60 (27.4)
University Education	10 (4.2)	4 (1.8)
City of origin			0.000
Porto Alegre	189 (80.1)	127 (57.7)
Metropolitan region	36 (15.3)	73 (33.2)
Countryside	11 (4.7)	20 (9.1)
Hospital admission	160 (67.8)	161 (73.2)	0.208
Initial CD4+ T-cell count			0.075
0-200 cells/mm3	91 (38.6)	71 (32.4)
201-500 cells/mm3	84 (35.6)	70 (32.0)
> 501 cells/mm3	61 (25.8)	78 (35.6)
Final CD4+ T-cell count			0.518
0-200 cells/mm3	17 (7.6)	20 (9.6)
201-500 cells/mm3	76 (33.8)	61 (29.3)
> 501 cells/mm3	132 (58.7)	127 (61.1)
Number of CD4+ T-cell /HIV-VL samples			0.316
1-3	53 (22.6)	55 (25.2)
4-6	103 (43.8)	104 (47.7)
7 or more	79 (33.6)	59 (27.1)
Number of ART schemes			0.215
1	164 (69.5)	142 (64.5)
2	44 (18.6)	56 (25.5)
> 3	24 (10.2)	21 (9.5)
Time of ART initiation			0.001
Up to 1 month	117 (50.4)	103 (47.0)
1-6 months	94 (40.5)	67 (30.6)
6-12 months	12 (5.2)	24 (11.0)
After 1 year	9 (3.9)	25 (11.4)

P < 0.05 considered significant. ART: Antiretroviral therapy; HIV-VL: Human immunodeficiency virus-viral load; HNSC: Nossa Senhora da Conceição Hospital.